PSYCHOL HEALTH 润色咨询

PSYCHOLOGY & HEALTH

出版年份：暂无数据 年文章数：2295 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1202340, encodeId=9ce01202340f8, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：质性研究;糖尿病<br>经验分享：差不多4个月给了拒信，不过审稿专家给了很多有益的建议，希望下次投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211212/206f19bc5ce748f58a48022e978b02c3/307ac41c887642c58fba83e6e626cab4.jpg, createdBy=6ac92165730, createdName=Shirley呀, createdTime=Sun Mar 13 22:29:27 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108591, encodeId=ec71110859136, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108592, encodeId=debe11085928f, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-03-13 Shirley呀

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向：质性研究;糖尿病
    经验分享：差不多4个月给了拒信，不过审稿专家给了很多有益的建议，希望下次投稿顺利！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1202340, encodeId=9ce01202340f8, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：质性研究;糖尿病<br>经验分享：差不多4个月给了拒信，不过审稿专家给了很多有益的建议，希望下次投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211212/206f19bc5ce748f58a48022e978b02c3/307ac41c887642c58fba83e6e626cab4.jpg, createdBy=6ac92165730, createdName=Shirley呀, createdTime=Sun Mar 13 22:29:27 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108591, encodeId=ec71110859136, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108592, encodeId=debe11085928f, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 rayms

    文章的局限性是什么？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1202340, encodeId=9ce01202340f8, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：质性研究;糖尿病<br>经验分享：差不多4个月给了拒信，不过审稿专家给了很多有益的建议，希望下次投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211212/206f19bc5ce748f58a48022e978b02c3/307ac41c887642c58fba83e6e626cab4.jpg, createdBy=6ac92165730, createdName=Shirley呀, createdTime=Sun Mar 13 22:29:27 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108591, encodeId=ec71110859136, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108592, encodeId=debe11085928f, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 rayms

    是否需要在讨论中说明文章局限性？

    1

    展开1条回复
共5条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分